(S (S (NP (NN Prostate) (NN cancer)) (VP (VBZ is) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (JJ common) (NNS diseases)) (PP (IN in) (NP (NNS men)))))))) (, ,) (CC and) (S (NP (PRP it)) (VP (VBZ is) (NP (NP (DT the) (ADJP (RBS most) (JJ common)) (JJ malignant) (NN tumor)) (PP (IN in) (NP (VBN developed) (NNS countries)))))) (. .))
(S (S (NP (NNS Studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (DT the) (JJ male) (NN prostate) (NN incidence) (NN rate)) (VP (VBZ is) (ADJP (RB as) (JJ high)) (PP (IN as) (NP (QP (CD 2.5) (NN %) (IN to) (CD 16) (NN %)))))))))) (, ,) (S (ADVP (RB Currently)) (, ,) (NP (NP (DT the) (NN inci) (HYPH -) (NN dence)) (PP (IN of) (NP (NP (NN prostate) (NN cancer)) (PP (IN in) (NP (NNP Asia)))))) (VP (VBZ is) (ADJP (ADJP (JJR lower)) (PP (IN than) (NP (NP (DT that)) (PP (IN in) (NP (DT the) (NNP West)))))))) (, ,) (CC but) (S (NP (PRP it)) (VP (VBZ is) (NP (NP (ADJP (JJ increas) (HYPH -))) (VP (VBG ing) (ADVP (RB rapidly)))))) (. .))
(S (SBAR (IN If) (S (NP (NN prostate) (NN cancer)) (VP (MD can) (VP (VB be) (VP (VP (VBN found) (PP (IN as) (NP (NP (JJ early)) (PP (IN as) (ADJP (JJ possible)))))) (CC and) (VP (VBN treated) (PP (IN in) (NP (NN time))))))))) (, ,) (NP (PRP it)) (VP (MD will) (VP (VB have) (NP (DT a) (JJ high) (NN survival) (NN rate)))) (. .))
(S (ADVP (RB Therefore)) (, ,) (NP (PRP it)) (VP (VBZ is) (PP (IN of) (NP (NP (JJ great) (NN significance)) (PP (IN for) (NP (NP (DT the) (NN diagnosis) (CC and) (NN treatment)) (PP (IN of) (NP (NN prostate) (NN cancer)))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBP propose) (NP (DT a) (NML (NN trans) (HYPH -) (NN fer)) (NN learning) (NN method)) (PP (VBN based) (PP (IN on) (NP (NP (JJ deep) (JJ neural) (NN network)) (PP (IN for) (NP (NN prostate) (NN MRI) (NN segmenta) (HYPH -) (NN tion))))))) (. .))
(S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP we)) (VP (VBP design) (NP (NP (DT a) (ADJP (JJ multi-level) (NN edge)) (NN attention) (NN module)) (VP (VBG using) (NP (NN wavelet) (NN decomposition)) (S (VP (TO to) (VP (VB overcome) (NP (NP (DT the) (NN difficulty)) (PP (IN of) (NP (JJ ambiguous) (NN boundary)))) (PP (IN in) (NP (NN prostate) (NN MRI) (NN segmentation) (NNS tasks))))))))) (. .))
(S (NP (DT The) (NN prostate) (NNS images)) (VP (VBD were) (VP (VBN provided) (PP (IN by) (NP (NP (NML (NNP MICCAI) (NNP Grand)) (NN Challenge) (HYPH -) (NN Prostate)) (NP (NML (NNP MR) (NNP Image) (NNP Segmentation)) (CD 2012) (-LRB- -LRB-) (NML (NN PROMISE) (CD 12)) (-RRB- -RRB-) (NN challenge) (NN dataset)))))) (. .))
